The supply of an unlicensed medicinal product in response to a bona fide unsolicited order, formulated in accordance with the specifications of an authorised health-care professional and for use by an individual patient under his direct personal responsibility. Is often termed ‘Named Patient Supply
Besides providing you with the relevant regulatory advice to ensure that you will be in full compliance with all legal requirements when supplying your unlicensed products, we are also able to offer help in all practical aspects, from completing the required documentation to arranging the necessary quality control, distribution and - if applicable - import provisions.
The medicines market is tightly regulated and the provision of a medicinal product generally requires a Marketing Authorisation, specifically issued for the product in question. However, EU legislation allows for the provision of unlicensed products if certain criteria are fulfilled.
Article 5 of EU Directive 2001/83/EC as amended
There are three main areas where named patient supply occurs.
If supply of an unlicensed medicine is needed in more than one member state then each member state has to be approached individually eg The Medicines for Human Use Regulations 1994 Schedule 1 covers what needs to be done for the UK. This is a complex area one that you are bound to need help with.